Surgery Cost Of Revenue vs Ebitda Analysis

SGRY Stock

USD 23.39 0.38 1.65%

Surgery Partners financial indicator trend analysis is much more than just breaking down Surgery Partners prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Surgery Partners is a good investment. Please check the relationship between Surgery Partners Cost Of Revenue and its Ebitda accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Surgery Partners. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more information on how to buy Surgery Stock please use our How to Invest in Surgery Partners guide.

Cost Of Revenue vs Ebitda

Cost Of Revenue vs Ebitda Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Surgery Partners Cost Of Revenue account and Ebitda. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Surgery Partners' Cost Of Revenue and Ebitda is 0.98. Overlapping area represents the amount of variation of Cost Of Revenue that can explain the historical movement of Ebitda in the same time period over historical financial statements of Surgery Partners, assuming nothing else is changed. The correlation between historical values of Surgery Partners' Cost Of Revenue and Ebitda is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cost Of Revenue of Surgery Partners are associated (or correlated) with its Ebitda. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ebitda has no effect on the direction of Cost Of Revenue i.e., Surgery Partners' Cost Of Revenue and Ebitda go up and down completely randomly.

Correlation Coefficient

0.98

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Cost Of Revenue

Cost of Revenue is found on Surgery Partners income statement and represents the costs associated with goods and services Surgery Partners provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Ebitda

Most indicators from Surgery Partners' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Surgery Partners current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Surgery Partners. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more information on how to buy Surgery Stock please use our How to Invest in Surgery Partners guide.At this time, Surgery Partners' Tax Provision is fairly stable compared to the past year. Sales General And Administrative To Revenue is likely to rise to 0.07 in 2024, whereas Selling General Administrative is likely to drop slightly above 80.8 M in 2024.

	2021	2022	2023	2024 (projected)
Interest Expense	221M	234.9M	193M	148.4M
Depreciation And Amortization	137.9M	149.6M	118.1M	80.6M

Interest Expense Depreciation And Amortization

Surgery Partners fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Good Will	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets
Common Stock Shares Outstanding		0.7	0.63	0.41	0.65	0.88	0.01	0.71	0.64	-0.77	0.76	0.54	0.69	0.92	0.14	0.63	0.54	0.72	0.67	0.61	0.73	0.29	0.89	0.53	0.88	0.69
Total Assets	0.7		0.98	0.83	0.98	0.77	0.39	0.96	0.97	-0.71	0.97	0.87	1.0	0.7	0.36	0.98	0.87	0.99	1.0	0.96	0.99	0.47	0.73	0.93	0.86	0.98
Short Long Term Debt Total	0.63	0.98		0.88	0.98	0.66	0.52	0.92	1.0	-0.7	0.92	0.88	0.98	0.6	0.41	1.0	0.88	0.97	0.98	0.99	0.96	0.4	0.64	0.95	0.81	0.96
Other Current Liab	0.41	0.83	0.88		0.83	0.45	0.44	0.71	0.88	-0.41	0.71	0.67	0.84	0.38	0.19	0.88	0.67	0.81	0.86	0.9	0.79	0.42	0.37	0.87	0.58	0.77
Total Current Liabilities	0.65	0.98	0.98	0.83		0.7	0.54	0.95	0.98	-0.75	0.94	0.92	0.97	0.63	0.43	0.98	0.92	0.98	0.96	0.96	0.97	0.35	0.69	0.93	0.85	0.98
Total Stockholder Equity	0.88	0.77	0.66	0.45	0.7		-0.07	0.79	0.66	-0.75	0.84	0.62	0.77	0.97	0.2	0.66	0.62	0.78	0.74	0.64	0.79	0.42	0.97	0.64	0.94	0.77
Other Liab	0.01	0.39	0.52	0.44	0.54	-0.07		0.33	0.5	-0.32	0.28	0.67	0.37	-0.14	0.65	0.52	0.67	0.42	0.39	0.51	0.39	-0.02	0.03	0.49	0.16	0.5
Property Plant And Equipment Net	0.71	0.96	0.92	0.71	0.95	0.79	0.33		0.92	-0.81	0.98	0.82	0.96	0.73	0.36	0.91	0.82	0.96	0.93	0.88	0.96	0.32	0.79	0.85	0.91	0.95
Net Debt	0.64	0.97	1.0	0.88	0.98	0.66	0.5	0.92		-0.71	0.92	0.86	0.97	0.6	0.38	1.0	0.86	0.97	0.98	0.98	0.96	0.37	0.63	0.94	0.81	0.95
Retained Earnings	-0.77	-0.71	-0.7	-0.41	-0.75	-0.75	-0.32	-0.81	-0.71		-0.78	-0.67	-0.7	-0.77	-0.33	-0.69	-0.67	-0.77	-0.66	-0.61	-0.77	0.1	-0.86	-0.6	-0.87	-0.77
Accounts Payable	0.76	0.97	0.92	0.71	0.94	0.84	0.28	0.98	0.92	-0.78		0.82	0.97	0.79	0.32	0.91	0.82	0.98	0.96	0.89	0.98	0.43	0.82	0.85	0.91	0.96
Cash	0.54	0.87	0.88	0.67	0.92	0.62	0.67	0.82	0.86	-0.67	0.82		0.86	0.51	0.64	0.88	1.0	0.87	0.86	0.87	0.86	0.35	0.64	0.89	0.74	0.93
Non Current Assets Total	0.69	1.0	0.98	0.84	0.97	0.77	0.37	0.96	0.97	-0.7	0.97	0.86		0.7	0.34	0.97	0.86	0.99	1.0	0.97	0.99	0.48	0.72	0.93	0.86	0.98
Non Currrent Assets Other	0.92	0.7	0.6	0.38	0.63	0.97	-0.14	0.73	0.6	-0.77	0.79	0.51	0.7		0.04	0.6	0.51	0.72	0.67	0.58	0.74	0.36	0.96	0.53	0.92	0.69
Other Assets	0.14	0.36	0.41	0.19	0.43	0.2	0.65	0.36	0.38	-0.33	0.32	0.64	0.34	0.04		0.4	0.64	0.37	0.35	0.39	0.34	0.02	0.25	0.42	0.3	0.46
Long Term Debt	0.63	0.98	1.0	0.88	0.98	0.66	0.52	0.91	1.0	-0.69	0.91	0.88	0.97	0.6	0.4		0.88	0.97	0.98	0.99	0.96	0.42	0.63	0.95	0.8	0.96
Cash And Short Term Investments	0.54	0.87	0.88	0.67	0.92	0.62	0.67	0.82	0.86	-0.67	0.82	1.0	0.86	0.51	0.64	0.88		0.87	0.86	0.87	0.86	0.35	0.64	0.89	0.74	0.93
Net Receivables	0.72	0.99	0.97	0.81	0.98	0.78	0.42	0.96	0.97	-0.77	0.98	0.87	0.99	0.72	0.37	0.97	0.87		0.98	0.95	1.0	0.42	0.76	0.91	0.87	0.99
Good Will	0.67	1.0	0.98	0.86	0.96	0.74	0.39	0.93	0.98	-0.66	0.96	0.86	1.0	0.67	0.35	0.98	0.86	0.98		0.98	0.98	0.51	0.69	0.94	0.83	0.97
Non Current Liabilities Total	0.61	0.96	0.99	0.9	0.96	0.64	0.51	0.88	0.98	-0.61	0.89	0.87	0.97	0.58	0.39	0.99	0.87	0.95	0.98		0.95	0.52	0.59	0.95	0.77	0.94
Inventory	0.73	0.99	0.96	0.79	0.97	0.79	0.39	0.96	0.96	-0.77	0.98	0.86	0.99	0.74	0.34	0.96	0.86	1.0	0.98	0.95		0.45	0.77	0.9	0.88	0.98
Other Current Assets	0.29	0.47	0.4	0.42	0.35	0.42	-0.02	0.32	0.37	0.1	0.43	0.35	0.48	0.36	0.02	0.42	0.35	0.42	0.51	0.52	0.45		0.27	0.44	0.29	0.41
Other Stockholder Equity	0.89	0.73	0.64	0.37	0.69	0.97	0.03	0.79	0.63	-0.86	0.82	0.64	0.72	0.96	0.25	0.63	0.64	0.76	0.69	0.59	0.77	0.27		0.59	0.95	0.76
Total Liab	0.53	0.93	0.95	0.87	0.93	0.64	0.49	0.85	0.94	-0.6	0.85	0.89	0.93	0.53	0.42	0.95	0.89	0.91	0.94	0.95	0.9	0.44	0.59		0.74	0.92
Property Plant And Equipment Gross	0.88	0.86	0.81	0.58	0.85	0.94	0.16	0.91	0.81	-0.87	0.91	0.74	0.86	0.92	0.3	0.8	0.74	0.87	0.83	0.77	0.88	0.29	0.95	0.74		0.86
Total Current Assets	0.69	0.98	0.96	0.77	0.98	0.77	0.5	0.95	0.95	-0.77	0.96	0.93	0.98	0.69	0.46	0.96	0.93	0.99	0.97	0.94	0.98	0.41	0.76	0.92	0.86

Click cells to compare fundamentals

Surgery Partners Account Relationship Matchups

Surgery Partners fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Common Stock Shares Outstanding	48.3M	48.8M	72.4M	92.0M	125.6M	131.9M
Total Assets	5.0B	5.4B	6.1B	6.7B	6.9B	4.6B
Short Long Term Debt Total	2.9B	3.2B	3.3B	2.9B	3.1B	2.5B
Other Current Liab	397.6M	353M	247.0M	242.5M	240.3M	253.3M
Total Current Liabilities	397.6M	556.8M	536.8M	493.4M	523M	371.2M
Total Stockholder Equity	297.8M	115.6M	1.1B	2.0B	2.0B	2.1B
Other Liab	62.9M	440.6M	402.6M	35M	40.3M	38.2M
Property Plant And Equipment Net	821M	854.7M	953.8M	1.2B	1.2B	641.9M
Net Debt	2.8B	2.9B	2.9B	2.6B	2.9B	2.3B
Retained Earnings	(315.7M)	(431.8M)	(502.7M)	(557.3M)	(569.2M)	(540.7M)
Accounts Payable	96.7M	100.2M	124.9M	151.6M	171.8M	97.0M
Cash	92.7M	317.9M	389.9M	282.9M	195.9M	185.4M
Non Current Assets Total	4.5B	4.6B	5.2B	5.8B	6.0B	4.0B
Non Currrent Assets Other	31.3M	27M	59.1M	144.2M	177.9M	186.8M
Other Assets	129.5M	554M	5.2B	122.3M	140.6M	133.6M
Long Term Debt	2.5B	2.8B	2.9B	2.6B	2.7B	2.2B
Cash And Short Term Investments	92.7M	317.9M	389.9M	282.9M	195.9M	185.4M
Net Receivables	326.9M	382.2M	430.2M	456.3M	496.4M	332.0M
Good Will	3.4B	3.5B	3.9B	4.1B	4.3B	3.1B
Liabilities And Stockholders Equity	5.0B	5.4B	6.1B	6.7B	6.9B	4.6B
Non Current Liabilities Total	2.9B	3.2B	3.3B	2.9B	3.0B	2.6B
Inventory	46.3M	56.4M	61.1M	71.4M	75.2M	48.1M
Other Current Assets	41.8M	45M	64.9M	110.4M	127.5M	86.4M
Other Stockholder Equity	268.7M	607.9M	1.6B	2.5B	2.5B	2.6B
Total Liab	5.0B	5.4B	6.1B	6.7B	3.5B	4.3B
Property Plant And Equipment Gross	821M	854.7M	1.2B	1.5B	1.7B	1.8B
Total Current Assets	525.5M	801.5M	946.1M	921M	895M	626.5M
Accumulated Other Comprehensive Income	(50.7M)	(61M)	(31.5M)	76.2M	57.5M	60.4M
Short Term Debt	93.3M	103.6M	100.5M	99.3M	110.9M	70.8M
Intangible Assets	47.3M	46.9M	43.7M	42.3M	54.8M	53.2M
Property Plant Equipment	821M	854.7M	953.8M	1.2B	1.3B	1.4B
Net Tangible Assets	(3.2B)	(2.4B)	1.1B	(1.6B)	(1.8B)	(1.9B)
Current Deferred Revenue	(190M)	109.8M	64.4M	3.2M	108.5M	113.9M
Long Term Investments	93.2M	90.3M	88.7M	190.3M	184.1M	99.2M
Short Long Term Debt	56M	64.4M	60.4M	62.8M	73.3M	55.9M
Warrants	1.1B	741.3M	330.2M	342M	393.3M	673.0M
Noncontrolling Interest In Consolidated Entity	686.6M	766.5M	880.6M	942.7M	1.1B	724.6M
Common Stock Total Equity	395.5M	435M	900K	1.3M	1.5M	1.4M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Surgery Stock Analysis

When running Surgery Partners' price analysis, check to measure Surgery Partners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgery Partners is operating at the current time. Most of Surgery Partners' value examination focuses on studying past and present price action to predict the probability of Surgery Partners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgery Partners' price. Additionally, you may evaluate how the addition of Surgery Partners to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Surgery Cost Of Revenue vs Ebitda Analysis

Cost Of Revenue vs Ebitda

Cost Of Revenue vs Ebitda Correlation Analysis

Correlation Coefficient

Cost Of Revenue

Ebitda

Surgery Partners fundamental ratios Correlations

Surgery Partners Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Surgery Partners fundamental ratios Accounts

Also Currently Popular

Additional Tools for Surgery Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Assets Total	+ 1.0	Total Assets
Good Will	+ 1.0	Total Assets
Net Debt	+ 1.0	Short Long Term Debt Total
Long Term Debt	+ 1.0	Short Long Term Debt Total
Long Term Debt	+ 1.0	Net Debt
Cash And Short Term Investments	+ 1.0	Cash

Property Plant And Equipment Gross	- 0.87	Retained Earnings
Other Stockholder Equity	- 0.86	Retained Earnings
Retained Earnings	- 0.81	Property Plant And Equipment Net
Accounts Payable	- 0.78	Retained Earnings
Total Current Assets	- 0.77	Retained Earnings
Inventory	- 0.77	Retained Earnings